During the past decade, Chase Brexton Health Services, Inc. conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chase Brexton Health Services, Inc." #1 sponsor was "Gilead Sciences" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Friends Research Institute, Inc." with 1 trials sponsored, "Merck Sharp & Dohme LLC" with 1 trials sponsored and "Tanox" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chase Brexton Health Services, Inc." #1 collaborator was "Duke University" with 1 trials as a collaborator, "Johns Hopkins University" with 1 trials as a collaborator, "NYU Langone Health" with 1 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator and "Virginia Commonwealth University" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Chase Brexton Health Services, Inc." are "HIV Infections" (6 trials), "HIV" (1 trials), "HIV Infection" (1 trials), "HIV-1 Infection" (1 trials) and "Substance Use Disorder" (1 trials). Many other conditions were trialed in "Chase Brexton Health Services, Inc." in a lesser frequency.

Most popular intervention types in "Chase Brexton Health Services, Inc." are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ATV" (1 trials), "Atripla" (1 trials), "COBI" (1 trials), "COBI placebo" (1 trials) and "FTC/TDF" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chase Brexton Health Services, Inc." are 9 trials for "All" genders.

Currently, there are NaN active trials in "Chase Brexton Health Services, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Chase Brexton Health Services, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chase Brexton Health Services, Inc., 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".